VYNE Therapeutics Inc (NAS:VYNE) Stock News, Headlines & Updates
VYNE Therapeutics Inc Stock News from GuruFocus
- 1
Jun 26, 2024
VYNE Therapeutics to Participate in Leerink Partners Therapeutics Forum
Marketwired • 7:00am
Jun 13, 2024
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202
Marketwired • 9:00am
Jun 05, 2024
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibitor VYN201
Marketwired • 7:00am
May 06, 2024
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
Marketwired • 7:00am
May 01, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news